See Also:
HWCI Research Associate Program

Follow


Submissions from 2026

 

Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy, Bruna Pellini

 

Early-Onset Oral Squamous Cell Carcinoma: Emerging Biological Insights, Risk Factors and Clinical Implications, Alessandro Villa

 

Effect of Timing of First Consultation with a Sarcoma Specialist Following Unplanned Excision: Oncologic Outcomes of Patients with Soft-Tissue Sarcomas, Juan Pretell

 

Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609), Manmeet Ahluwalia and Zouina Sarfraz

 

Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3, Guenther Koehne

 

Enhancing lung cancer screening through 'saved by the scan': insights from a multipronged public service advertising campaign, Logan Spiegelman, Kristen Ordonez, Papsy Mileti, Debbie Ferrera Aguiar, Bianca Hernandez, Stacy Pagan, Juan Batlle, Mark Dylewski, Valerie Bethel, and Manmeet Ahluwalia

 

ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysis, Rupesh Kotecha

 

Evaluation of a Dynamic Collimation System to Improve IMPT Dose Distributions and Maintain Treatment Efficiency, Alonso Gutierrez, Andrew Wroe, and Eduardo Pons

 

Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease, Camila Masias

 

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data, Ana Sandoval Leon

 

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data, Ana Sandoval Leon

 

Family Impact of Burning Mouth Syndrome: A Cross-Sectional Study Using FROM-16, Alessandro Villa

 

Focused ultrasound for brain metastases, Michael McDermott and Manmeet Ahluwalia

 

Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients, Michael McDermott

 

From Information Overload to Patient-Centered Oncology Care Through Apomediation, Manmeet Ahluwalia

 

Future Directions and Emerging Approaches in the Treatment of Brain Metastases, Minesh Mehta

 

Gaining New Ground: The Evolving Role of Radiation Therapy in Esophageal Cancer, Michael Chuong

 

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results, Rohan Garje

 

Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023, Arjun Pon Avudaiappan

 

Global Consensus on the Management of Primary Localized Chordoma, Minesh Mehta

 

Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression, Maria Abreu and Guenther Koehne

 

Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression, Maria Abreu and Guenther Koehne

 

High-resolution scintillation imaging for detecting delivery errors in preclinical ultrahigh dose rate proton beam therapy, James Kraus

PDF

Imaging Outcomes After Middle Meningeal Artery Embolization for Chronic Subdural Hematoma, Shakthi Kumaran Ramasamy

 

Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression, Alessandro Villa